CORPORATE SOCIAL PRACTICES IN BANGLADESH: A STUDY ON PHARMACEUTICAL SECTORS IN BANGLADESH. Report On CORPORATE SOCIAL PRACTICES IN BANGLADESH: A STUDY ON PHARMACEUTICAL SECTORS IN BANGLADESH. Course Code: BUS-498 Submitted to: Md. Jahirul Islam Lecturer‚ ASAUB Submitted by: Farhana Bhuiyan ID# 073-12-0020 BBA 3rd Batch‚ ASAUB [pic] ASA UNIVERSITY BANGLADESH December‚ 2011 Declaration of originality
Premium Corporate social responsibility
Bangladesh Small and Cottage Industries Corporation (BSCIC) provides a package of services to private sector entrepreneurs in Bangladesh in the small and cottage industries sector. It was created through an Act of Parliament in 1957 which was later amended in 1992. BSCIC has developed a total of 74 industrial estates throughout the country to foster the growth of SCIs in a balanced manner and also construction works for good number of estates including special type like Tannery‚ API (Active Pharmaceutical
Premium Industry Bangladesh Bengal
Research on Pharmaceutical Channel Distribution 2013 Medhad Nasser Chowdhury 082735530 4/30/2013 MKT 450.1 Faculty Members: Shahed Hussain The New Era A journey through the pharmaceutical channel system in Bangladesh Abstract The aim of the study is to analyze the changes that took place in Bangladesh Pharmaceutical Industries Channel system in the past decade. The current scenario of the pharmaceutical Industry in Bangladesh and external effects that might bring in
Premium Marketing Pharmaceutical industry Supply chain
Bangladesh Association of Pharmaceutical Industries (BAPI)‚ the stalwart association of pharmaceutical manufacturers of the country was instituted in 1972‚ Since then BAPI playing a pivotal role in shaping up the industry. Association’s member include large‚ medium‚ small‚ national and foreign companies who together are responsible for manufacturing 96% of the country’s pharmaceutical production. This indeed proves the success of BAPI as a responsible and acceptable body. Prospect of medicine
Premium Uzbekistan Soviet Union Pharmacology
The Global Pharmaceutical Industry Date: 2011 August 20 Table of content Contents Page 1. Introduction 4 2. Pestel analysis of the global pharmaceutical industries 5-6 3. Drivers for change in the future of pharmaceutical 7 4. Five forces analysis on the global pharmaceutical industry 8-10 5. Threats to a big pharmaceutical company 11 6. Conclusion 12 7. Bibliography 13 Introduction The pharmaceutical industry According
Premium Pharmaceutical industry Generic drug Barriers to entry
Today the pharmaceutical industry is one of the biggest industries in the United States. The industry experienced a rapid growth rate (in the double digits) in the late 20th century which has now dropped into the single digits (Mullins‚ 2007). The global demand is driven by factors such as a worldwide increase in elderly population and a rising quality of life in developing nations. Time Magazine listed Generic Pharmaceutical Manufacturing as one of the top ten fastest growing industries in the United
Premium Pharmacology Pharmaceutical industry Pharmacy
focused on pharmaceuticals in efforts to control rising healthcare expenditure. • Inter-country pricing disparities. Economic • European free trade agreements. Social • Ageing populations create pressure on healthcare systems. • Epidemic or chronic diseases (e.g. obesity). Technological • Impact of genetic research on industry. • Utilizing a web of alliances to address multiple customer needs Environmental • Increasing standards and requirements for environmental protection
Premium Generic drug Pharmaceutical industry Regulation
References: 1. Heavy Metals (incl. Lead and Iron); 1st April‚ 2011 http://www.home-water-purifiers-and-filters.com/lead.php Heavy Metals in Water‚ Sediment and Some Fishes of Buriganga River‚ Bangladesh; 27th March‚ 2011 http://www.sid.ir/en/VEWSSID/J_pdf/108220100216.pdf 8. Heavy Metal (Chemistry); 29th March‚ 2011 http://en.wikipedia.org/wiki/Heavy_metal_%28chemistry%29
Premium Water Mercury Water pollution
R&D and manufacturing facilities receive ISO 9001 certification from RWTUV‚ Germany 1994 Biocon establishes Syngene International Pvt. Ltd. as a Custom research Company (CRC) to address the growing need for outsourced R&D in the pharmaceutical sector 1996 The commercial success of Biocon’s proprietary fermentation plant leads to a 3-fold expansion Biocon leverages its technology platform to enter biopharmaceuticals and statins 1998 Unilever inks a deal with ICI to sell
Premium Pharmaceutical industry Marketing Pharmacology
Introduction Pfizer‚ US pharmaceutical company is one of the largest pharmaceutical companies in the world. Unfortunately‚ Pfizer faced challenges by macro-environment forces that affect their sales volume decline dramatically in 2011. PESTEL‚ Porter’s Five Forces and Industry Lift Cycle frameworks to be applied to analysis the broad macro-environment that affected Pfizer in the pharmaceutical industry. 1. PESTEL framework PESTEL (Appendix I) is classifies into six environmental influences including
Premium Pharmaceutical industry Pharmacology Food and Drug Administration